159 related articles for article (PubMed ID: 1489407)
1. Hodgkin's lymphoma. II: Treatment and delayed morbidity.
Carde P
BMJ; 1992 Jul; 305(6846):173-6. PubMed ID: 1489407
[No Abstract] [Full Text] [Related]
2. Evolution of the concept of prognostication in therapy of Hodgkin's lymphoma.
Klimo P
Leuk Lymphoma; 1995; 15 Suppl 1():15-8. PubMed ID: 7767252
[No Abstract] [Full Text] [Related]
3. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
[TBL] [Abstract][Full Text] [Related]
4. Integrating radiotherapy into bone marrow transplantation programs for Hodgkin's disease.
Yahalom J
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):525-8. PubMed ID: 7673043
[No Abstract] [Full Text] [Related]
5. [Autologous bone marrow transplantation in Hodgkin's disease].
Schmitz N; Gassmann W; Kayser W; Löffler H
Dtsch Med Wochenschr; 1987 Feb; 112(8):314-20. PubMed ID: 3545750
[No Abstract] [Full Text] [Related]
6. [Therapy of recurrent Hodgkin's lymphoma. II. The value of bone marrow transplantation].
Pfreundschuh M; Diehl V
Dtsch Med Wochenschr; 1989 Jun; 114(23):916-21. PubMed ID: 2656189
[No Abstract] [Full Text] [Related]
7. Role of chemoresistance prior to autologous bone marrow transplantation for Hodgkin's disease.
Voillat L; Deconinck E; Flesch M; Brion A; Rozenbaum A; Vuillier J; Pavy JJ; Angonin R; Carbillet JP; Hervé P
Nouv Rev Fr Hematol (1978); 1994 Dec; 36(6):423-30. PubMed ID: 7753613
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
[TBL] [Abstract][Full Text] [Related]
9. Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma.
Horning SJ; Negrin RS; Chao JC; Long GD; Hoppe RT; Blume KG
J Clin Oncol; 1994 Dec; 12(12):2552-8. PubMed ID: 7989928
[TBL] [Abstract][Full Text] [Related]
10. Indications for high-dose therapy with hematopoietic support in patients with Hodgkin's disease.
Phillips GL; Longo DL
Leukemia; 1993 Jul; 7(7):1087-90. PubMed ID: 8321031
[No Abstract] [Full Text] [Related]
11. Clinical course and outcome of patients with Hodgkin's disease who progress after autologous transplantation.
Varterasian M; Ratanatharathorn V; Uberti JP; Karanes C; Abella E; Momin F; Kasten-Sportes C; Al-Katib A; Lum L; Heilbrun LK
Leuk Lymphoma; 1995 Dec; 20(1-2):59-65. PubMed ID: 8750624
[TBL] [Abstract][Full Text] [Related]
12. Salvage treatment for Hodgkin's disease in relapse.
Bergsagel DE
J Clin Oncol; 1987 Apr; 5(4):525-6. PubMed ID: 3549985
[No Abstract] [Full Text] [Related]
13. [Bone marrow transplantation in the concept of the step-by-step therapy of refractory or recurrent Hodgkin's lymphoma].
Thomas M; Schneider W; Aul C; Heyll A
Dtsch Med Wochenschr; 1990 Oct; 115(41):1566-70. PubMed ID: 2209447
[No Abstract] [Full Text] [Related]
14. Treatment of Hodgkin's lymphoma.
McMillan A; Pearce R; Chopra R; Goldstone AH; Linch DC
BMJ; 1992 Aug; 305(6849):367. PubMed ID: 1392905
[No Abstract] [Full Text] [Related]
15. High-dose cytotoxic therapy and bone marrow transplantation for relapsed Hodgkin's disease.
Jones RJ; Piantadosi S; Mann RB; Ambinder RF; Seifter EJ; Vriesendorp HM; Abeloff MD; Burns WH; May WS; Rowley SD
J Clin Oncol; 1990 Mar; 8(3):527-37. PubMed ID: 2307990
[TBL] [Abstract][Full Text] [Related]
16. [Recent progress in the treatment of hematological malignancies. V. Recent results of chemotherapy and major prognostic factors in patients with T-cell lymphoma, B-cell lymphoma and Hodgkin's disease].
Ohta K; Shimoyama M
Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):802-8. PubMed ID: 2794662
[No Abstract] [Full Text] [Related]
17. [The place of bone marrow autografts in the treatment of Hodgkin's and non-Hodgkin's lymphoma].
Gisselbrecht C; Lepage E; Brice P; Trédaniel J; Gerota I
Nouv Rev Fr Hematol (1978); 1988; 30(1-2):131-4. PubMed ID: 2455276
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
Wheeler C; Antin JH; Churchill WH; Come SE; Smith BR; Bubley GJ; Rosenthal DS; Rappaport JM; Ault KA; Schnipper LE
J Clin Oncol; 1990 Apr; 8(4):648-56. PubMed ID: 2313334
[TBL] [Abstract][Full Text] [Related]
19. Autologous bone marrow transplantation for Hodgkin's disease--a five-year single centre experience.
Ager S; Wimperis JZ; Tolliday B; Jestice K; Bass G; Baglin T; Marcus RE
Leuk Lymphoma; 1994 Apr; 13(3-4):263-72. PubMed ID: 8049649
[TBL] [Abstract][Full Text] [Related]
20. Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study.
Ali A; Sayed H; Farrag A; El-Sayed M
Leuk Res; 2010 Nov; 34(11):1447-52. PubMed ID: 20599270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
